(Flickr photo (cropped) by Francis Bourgouin).
A large trial of Crestor was stopped early because it reduced inflammation and the risk of a heart attack. How should we interpret the JUPITER trial, and what does it mean for you?
Explore the stories behind the health headlines.
Guests: Paul Ridker, MD, Professor of Medicine at the Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention at the Brigham & Women’s Hospital in Boston, MA. He led the JUPITER trial of Crestor against CRP. The photo is of Dr. Ridker.
Nortin Hadler, MD, Professor of Medicine, Microbiology and Immunology at the University of North Carolina at Chapel Hill. He is attending rheumatologist at UNC Hospitals. His books include The Last Well Person: How to Stay Well Despite the Health Care System and Worried Sick: A Prescription for Health in an Overtreated America.
Stephen Sinatra, MD, FACC, cardiologist at the New England Heart Center in Manchester, CT. He edits the monthly newsletter, “Heart, Health and Nutrition” and is author of several books, including The Sinatra Solution. His Web site is drsinatra.com.